BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24289586)

  • 21.
    Liu ZQ; Chen GG; Sun RL; Chen C; Lu MY; Guan LF; Chi XL; Jian YQ; Zhu X; Liu RQ; Cai BY; Chen FF; Liu B
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30139812
    [No Abstract]   [Full Text] [Related]  

  • 22. [XP gene polymorphisms and haplotypes with genetic susceptibility to lung cancer].
    Huang Y; Meng C; Long W; Liu Y; Liu Y; Yang J; Yan Z; Yu D; Xiao S
    Wei Sheng Yan Jiu; 2019 Nov; 48(6):919-924. PubMed ID: 31875816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
    Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients.
    Le Morvan V; Longy M; Bonaïti-Pellié C; Bui B; Houédé N; Coindre JM; Robert J; Pourquier P
    Int J Cancer; 2006 Oct; 119(7):1732-5. PubMed ID: 16646069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between XPG polymorphisms and cancer susceptibility: Evidence from observational studies.
    Han C; Huang X; Hua R; Song S; Lyu L; Ta N; Zhu J; Zhang P
    Medicine (Baltimore); 2017 Aug; 96(32):e7467. PubMed ID: 28796034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of XPG and MMS19L polymorphisms response to chemotherapy in osteosarcoma.
    Zhao YL; Yang LB; Geng XL; Zhou QL; Qin H; Yang L; Dong YZ; Zhong JJ
    Pak J Med Sci; 2013 Sep; 29(5):1225-9. PubMed ID: 24353725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
    Li Y; Liu Z; Liu H; Wang LE; Onodera H; Suzuki A; Suzuki K; Wadhwa R; Elimova E; Sudo K; Shiozaki H; Estrella J; Lee JS; Song S; Tan D; Ajani JA; Wei Q
    Carcinogenesis; 2014 Sep; 35(9):2031-8. PubMed ID: 24990617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in XPC gene and risk for prostate cancer.
    Said R; Bougatef K; Setti Boubaker N; Jenni R; Derouiche A; Chebil M; Ouerhani S
    Mol Biol Rep; 2019 Feb; 46(1):1117-1125. PubMed ID: 30552616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An insight into clinical outcome of XPG polymorphisms in breast cancer.
    Malik SS; Mubarik S; Masood N; Khadim MT
    Mol Biol Rep; 2018 Dec; 45(6):2369-2375. PubMed ID: 30255276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit.
    Bau DT; Tsai MH; Huang CY; Lee CC; Tseng HC; Lo YL; Tsai Y; Tsai FJ
    Chin J Physiol; 2007 Dec; 50(6):294-300. PubMed ID: 18442012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
    Sun K; Gong A; Liang P
    Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of polymorphisms in nucleotide excision repair pathway genes with susceptibility to cutaneous melanoma.
    Hashemzehi A; Ghadyani M; Asadian F; Dastgheib SA; Kargar S; Neamatzadeh H; Akbarian E; Emarati A
    Klin Onkol; 2021; 34(5):350-355. PubMed ID: 34702042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variations in nucleotide excision repair pathway genes and hepatoblastoma susceptibility.
    Zhuo Z; Miao L; Hua W; Chen H; Yang Z; Li Y; Zhang J; Li S; Cheng J; Li L; Xia H; He J
    Int J Cancer; 2021 Nov; 149(9):1649-1658. PubMed ID: 34196959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
    Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common variants of xeroderma pigmentosum genes and prostate cancer risk.
    Mirecka A; Paszkowska-Szczur K; Scott RJ; Górski B; van de Wetering T; Wokołorczyk D; Gromowski T; Serrano-Fernandez P; Cybulski C; Kashyap A; Gupta S; Gołąb A; Słojewski M; Sikorski A; Lubiński J; Dębniak T
    Gene; 2014 Aug; 546(2):156-61. PubMed ID: 24933002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.
    Zhang Y; Li P; Xu A; Chen J; Ma C; Sakai A; Xie L; Wang L; Na Y; Kaku H; Xu P; Jin Z; Li X; Guo K; Shen H; Zheng S; Kumon H; Liu C; Huang P
    Tumour Biol; 2016 May; 37(5):6653-9. PubMed ID: 26646562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists.
    Rajaraman P; Bhatti P; Doody MM; Simon SL; Weinstock RM; Linet MS; Rosenstein M; Stovall M; Alexander BH; Preston DL; Sigurdson AJ
    Int J Cancer; 2008 Dec; 123(11):2713-6. PubMed ID: 18767034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
    Saldivar JS; Lu KH; Liang D; Gu J; Huang M; Vlastos AT; Follen M; Wu X
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S223-9. PubMed ID: 17825393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
    Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.